Elanco Animal Health, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US28414H1032
USD
24.44
0.46 (1.92%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Halozyme Therapeutics, Inc.
Amgen, Inc.
Illumina, Inc.
Gilead Sciences, Inc.
Moderna, Inc.
Bio-Techne Corp.
BioMarin Pharmaceutical, Inc.
Biogen, Inc.
Elanco Animal Health, Inc.
Vaxcyte, Inc.
Immunovant, Inc.

Why is Elanco Animal Health, Inc. ?

Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Elanco Animal Health, Inc. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Elanco Animal Health, Inc.
132.1%
0.33
50.44%
S&P 500
16.12%
0.70
20.15%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
9.47%
EBIT Growth (5y)
18.65%
EBIT to Interest (avg)
0.90
Debt to EBITDA (avg)
5.95
Net Debt to Equity (avg)
0.62
Sales to Capital Employed (avg)
0.39
Tax Ratio
30.41%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
2.12%
ROE (avg)
2.44%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
104
Industry P/E
Price to Book Value
1.72
EV to EBIT
62.87
EV to EBITDA
16.63
EV to Capital Employed
1.48
EV to Sales
3.30
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
2.35%
ROE (Latest)
1.65%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 629 MM

RAW MATERIAL COST(Y)

Fallen by -4.57% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at 52.14 %

DEBTORS TURNOVER RATIO(HY)

Highest at 4.89 times

-17What is not working for the Company
PRE-TAX PROFIT(Q)

Lowest at USD -27 MM

NET PROFIT(Q)

Lowest at USD -11 MM

EPS(Q)

Lowest at USD -0.07

Here's what is working for Elanco Animal Health, Inc.

Operating Cash Flow
Highest at USD 629 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Debt-Equity Ratio
Lowest at 52.14 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Debtors Turnover Ratio
Highest at 4.89 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -4.57% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at USD 176 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for Elanco Animal Health, Inc.

Pre-Tax Profit
At USD -27 MM has Fallen at -116.64%
over average net sales of the previous four periods of USD 162.25 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD -11 MM has Fallen at -108.95%
over average net sales of the previous four periods of USD 122.92 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Pre-Tax Profit
Lowest at USD -27 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit
Lowest at USD -11 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (USD MM)

EPS
Lowest at USD -0.07
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (USD)